Global Facial Injectables Market research Report - Forecast to 2021

Tuesday, April 17, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, April 17, 2018 /PRNewswire/ -- Introduction Facial Injectable or also known as Dermal Fillers are products which

help in a trending application known as bio-engineering or facial rejuvenation. As humans age the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles hence smile lines and wrinkles over the
face become more visible.Download the full report: Global Facial Injectable market has been segmented on the basis of types which comprises of Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers and Particles and others. On the basis of end users which consists of hospitals, clinics, research and development facilities and others. On the basis of application which consists of facial surgery, facial uplift and others.The global market for Facial Injectable is expected to reach US$ 9043.9 million by the end of the forecasted period and is expected to grow at a CAGR of 13.2%.Key PlayersThe key players profiled in the research report are Allergan Inc (Ireland), Merz Pharma (Germany), Ipsen (France), Valeant Pharmaceuticals (Canada), Galderma (Switzerland), Integra Lifesciences (US), Tei Biosciences, Fibrogen (Finland), Ethicon (US) and others.Study Objectives: •  To provide insights about factors, influencing and affecting the market growth.•  To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.•  To provide historical and forecast revenue of the market segments based on types, application, end user and others.•  To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.Target Audience• Facial Injectable manufacturers• Facial Injectable Suppliers• Pharmaceutical companies• Research and Development (R&D) Companies• Medical Research Laboratories• Academic Medical Institutes and UniversitiesKey Findings• The global Facial Injectable market and is expected to reach USD 9043.9 million by 2021.• Regionally, North America holds the largest market share of global Facial Injectable market and is expected to reach USD 3428.2 million by 2021.• Asia Pacific market is expected to be the fastest growing market, and expected to grow at a CAGR of 13.6% from 2016 to 2021The reports also cover country level analysis:America• North AmericaEuropeWestern EuropeGermanyFranceItalySpain• UK• Rest of Western EuropeEastern EuropeAsiaChinaIndiaJapanSouth Korea• Rest of AsiaMiddle East & AfricaDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store